Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.PACB · Entity 5650 | Director | June 03, 2026 | June 04, 2026 |
| QUIDEL CORP /DE/QDEL · Entity 126712 | Director | May 18, 2021 | May 20, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Report date June 03, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.58 · Expires 2036-06-03 | Direct | 223,492 |
Reported balance
After 2026-06-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-03 · Grant · Acquired 223,492 · Balance 223,492 F1: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates.
QUIDEL CORP /DE/
Report date May 18, 2021 · Filed May 20, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Units (Equity Grant)SEC Table II · derivative / convertible security | Direct | 1,624 |
Reported balance
After 2021-05-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-05-18 · Grant · Acquired 1,624 · Balance 1,624 F1: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F2: The restricted stock units vest on May 18, 2022. |
| Restricted Stock Units (Converted)SEC Table II · derivative / convertible security | Direct | 427 |
Reported balance
After 2021-05-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-05-18 · Grant · Acquired 427 · Balance 427 F1: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F3: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F4: The restricted stock units vest on the date of the grant, May 18, 2021. |
| Restricted Stock Units (Premium)SEC Table II · derivative / convertible security | Direct | 42 |
Reported balance
After 2021-05-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-05-18 · Grant · Acquired 42 · Balance 42 F1: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F2: The restricted stock units vest on May 18, 2022. F3: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock.
F2: The restricted stock units vest on May 18, 2022.
F3: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule.
F4: The restricted stock units vest on the date of the grant, May 18, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2026 Filed Jun 4, 2026 21:20 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 223,492 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001299130-26-000094 · wk-form4_1780608047.xml · derivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,492 Underlying: Common Stock · 223,492 shares Expires 2036-06-03 F1 · derivative.exercise_date: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:09 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001299130-25-000136 · wk-form4_1749240563.xml · derivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2035-06-04 F1 · derivative.exercise_date: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates. Read SEC document |
| June 18, 2024 Filed Jun 20, 2024 21:02 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 32,179 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0001299130-24-000154 · wk-form4_1718917337.xml · derivative · entry 2 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,179 Underlying: Common Stock · 32,179 shares Expires 2034-06-18 F2 · derivative.exercise_date: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates. Read SEC document |
| June 18, 2024 Filed Jun 20, 2024 21:02 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 22,821 | $0.00 | $0.00 |
DisclosureSEC source: 0001299130-24-000154 · wk-form4_1718917337.xml · nonDerivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 403,037 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest on the one (1) year anniversary of the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:24 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionStock Option (right to buy) · Derivative | 37,106 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001299130-24-000079 · wk-form4_1710879811.xml · derivative · entry 4 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,106 shares Expires 2028-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:24 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionStock Option (right to buy) · Derivative | 324,515 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001299130-24-000079 · wk-form4_1710879811.xml · derivative · entry 3 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 324,515 shares Expires 2027-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:24 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionCommon Stock | 37,106 | $2.63 | $97,588.78 |
DisclosureSEC source: 0001299130-24-000079 · wk-form4_1710879811.xml · nonDerivative · entry 2 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 380,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:24 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionCommon Stock | 324,515 | $2.90 | $941,093.50 |
DisclosureSEC source: 0001299130-24-000079 · wk-form4_1710879811.xml · nonDerivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 343,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2023 Filed May 26, 2023 20:37 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 25,775 | $0.00 Strike: $11.94 | $0.00 |
DisclosureSEC source: 0001299130-23-000076 · wf-form4_168513343005461.xml · derivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,775 Underlying: Common Stock · 25,775 shares Expires 2033-05-24 F1 · derivative.exercise_date: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates. Read SEC document |
| May 25, 2022 Filed May 27, 2022 23:29 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 63,015 | $0.00 Strike: $5.37 | $0.00 |
DisclosureSEC source: 0001299130-22-000083 · certent-form4.xml · derivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,015 Underlying: Common Stock · 63,015 shares Expires 2032-05-25 F1 · derivative.exercise_date: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 01:11 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 3,280 | $11.50 | $37,720.00 |
DisclosureSEC source: 0001299130-22-000022 · certent-form4.xml · nonDerivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,595 F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $11.50 to $11.505 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 16, 2021 Filed Jun 22, 2021 01:21 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 12,885 | $0.00 Strike: $27.90 | $0.00 |
DisclosureSEC source: 0001299130-21-000180 · certent-form4.xml · derivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,885 Underlying: Common Stock · 12,885 shares Expires 2031-06-16 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, or, if earlier, on the date of the next annual meeting of stockholders, provided the Reporting Person continues to serve as a director through each vesting date. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:31 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units (Premium) · Derivative | 42 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034698 · doc4.xml · derivative · entry 3 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42 Underlying: Common Stock · 42 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 18, 2022. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units vest on May 18, 2022. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:31 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units (Converted) · Derivative | 427 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034698 · doc4.xml · derivative · entry 2 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427 Underlying: Common Stock · 427 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F4 · derivative.exercise_date: The restricted stock units vest on the date of the grant, May 18, 2021. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F4 · derivative.expiration_date: The restricted stock units vest on the date of the grant, May 18, 2021. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:31 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units (Equity Grant) · Derivative | 1,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034698 · doc4.xml · derivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,624 Underlying: Common Stock · 1,624 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 18, 2022. F2 · derivative.expiration_date: The restricted stock units vest on May 18, 2022. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:08 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units · Derivative | 1,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032970 · doc4.xml · derivative · entry 2 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,040 shares Expires 2021-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:08 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 1,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032970 · doc4.xml · nonDerivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects release of restricted stock units that were previously reported on Form 4. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:52 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionStock Option (right to buy) · Derivative | 50,394 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001299130-21-000070 · certent-form4.xml · derivative · entry 15 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,106 Underlying: Common Stock · 50,394 shares Expires 2028-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest in equal monthly installment, over a four year period Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:52 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionStock Option (right to buy) · Derivative | 25,485 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001299130-21-000070 · certent-form4.xml · derivative · entry 14 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,515 Underlying: Common Stock · 25,485 shares Expires 2027-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest in equal monthly installment, over a four year period Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:52 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $3.81 | $0.00 |
DisclosureSEC source: 0001299130-21-000070 · certent-form4.xml · derivative · entry 13 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2027-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:52 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $8.98 | $0.00 |
DisclosureSEC source: 0001299130-21-000070 · certent-form4.xml · derivative · entry 12 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2026-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:52 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.79 | $0.00 |
DisclosureSEC source: 0001299130-21-000070 · certent-form4.xml · derivative · entry 11 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2025-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:52 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $6.98 | $0.00 |
DisclosureSEC source: 0001299130-21-000070 · certent-form4.xml · derivative · entry 10 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,000 shares Expires 2024-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:52 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 1,100 | $49.00 | $53,900.00 |
DisclosureSEC source: 0001299130-21-000070 · certent-form4.xml · nonDerivative · entry 9 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,875 Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:52 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 101,004 | $48.47 | $4,895,259.86 |
DisclosureSEC source: 0001299130-21-000070 · certent-form4.xml · nonDerivative · entry 8 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,975 F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $48.00 to $48.98 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4 Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:52 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 118,667 | $47.58 | $5,646,650.53 |
DisclosureSEC source: 0001299130-21-000070 · certent-form4.xml · nonDerivative · entry 7 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,979 F1 · price: This sale price represents the weighted average sale price of the shares sold ranging from $47.00 to $47.99 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4 Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:52 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionCommon Stock | 50,394 | $2.63 | $132,536.22 |
DisclosureSEC source: 0001299130-21-000070 · certent-form4.xml · nonDerivative · entry 6 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:52 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionCommon Stock | 25,485 | $2.90 | $73,906.50 |
DisclosureSEC source: 0001299130-21-000070 · certent-form4.xml · nonDerivative · entry 5 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:52 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionCommon Stock | 25,000 | $3.81 | $95,250.00 |
DisclosureSEC source: 0001299130-21-000070 · certent-form4.xml · nonDerivative · entry 4 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:52 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionCommon Stock | 25,000 | $8.98 | $224,500.00 |
DisclosureSEC source: 0001299130-21-000070 · certent-form4.xml · nonDerivative · entry 3 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:52 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionCommon Stock | 25,000 | $5.79 | $144,750.00 |
DisclosureSEC source: 0001299130-21-000070 · certent-form4.xml · nonDerivative · entry 2 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 02:52 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionCommon Stock | 35,000 | $6.98 | $244,300.00 |
DisclosureSEC source: 0001299130-21-000070 · certent-form4.xml · nonDerivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 22:47 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 97,785 | $0.00 Strike: $3.89 | $0.00 |
DisclosureSEC source: 0001209191-20-045573 · doc4.xml · derivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,785 Underlying: Common Stock · 97,785 shares Expires 2030-08-04 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, or if earlier, on the date of the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director through each vesting date. Read SEC document |
| May 14, 2020 Filed May 18, 2020 20:10 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units · Derivative | 1,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030264 · doc4.xml · derivative · entry 2 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,856 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On June 20, 2019, the reporting person was granted 1,856 restricted stock units vesting on the May 14, 2020. F3 · derivative.expiration_date: On June 20, 2019, the reporting person was granted 1,856 restricted stock units vesting on the May 14, 2020. Read SEC document |
| May 14, 2020 Filed May 18, 2020 20:10 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 1,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030264 · doc4.xml · nonDerivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects release of restricted stock units that were previously reported on Form 4. Read SEC document |
| May 12, 2020 Filed May 14, 2020 19:49 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units (Equity Grant) · Derivative | 1,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029373 · doc4.xml · derivative · entry 3 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,040 Underlying: Common Stock · 1,040 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F4 · derivative.exercise_date: The restricted stock units vest on May 12, 2021. F4 · derivative.expiration_date: The restricted stock units vest on May 12, 2021. Read SEC document |
| May 12, 2020 Filed May 14, 2020 19:49 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units (Premium) · Derivative | 54 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029373 · doc4.xml · derivative · entry 2 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54 Underlying: Common Stock · 54 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F2 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F4 · derivative.exercise_date: The restricted stock units vest on May 12, 2021. F2 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F4 · derivative.expiration_date: The restricted stock units vest on May 12, 2021. Read SEC document |
| May 12, 2020 Filed May 14, 2020 19:49 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units (Converted) · Derivative | 273 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029373 · doc4.xml · derivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273 Underlying: Common Stock · 273 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F2 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F3 · derivative.exercise_date: The restricted stock units vest on the date of the grant, May 12, 2020. F2 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F3 · derivative.expiration_date: The restricted stock units vest on the date of the grant, May 12, 2020. Read SEC document |
| June 20, 2019 Filed Jun 24, 2019 20:00 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units · Derivative | 1,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-038860 · doc4.xml · derivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,856 Underlying: Common Stock · 1,856 shares Expires 2020-05-14 F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 01:46 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 6,933 | $7.17 | $49,695.74 |
DisclosureSEC source: 0001209191-19-011850 · doc4.xml · nonDerivative · entry 2 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,767 F2 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units and performance awards. F3 · price: This sale price represents the weighted average sale price of the shares sold ranging from $7.16 to $7.18 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| February 15, 2019 Filed Feb 21, 2019 01:46 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 19,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011850 · doc4.xml · nonDerivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,700 F1 · shares: Represents the number of shares earned upon satisfaction of performance goals in connection with performance-based restricted stock units. Read SEC document |
| November 27, 2018 Filed Nov 28, 2018 21:03 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-18-060103 · doc4.xml · derivative · entry 3 ORDONEZ KATHY · CIK 0001222643 · Director · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 25,000 shares Expires 2027-11-15 F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a four year period. Read SEC document |
| November 27, 2018 Filed Nov 28, 2018 21:03 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 25,000 | $7.54 | $188,500.00 |
DisclosureSEC source: 0001209191-18-060103 · doc4.xml · nonDerivative · entry 2 ORDONEZ KATHY · CIK 0001222643 · Director · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,750 F1 · price: This sale price represents the weighted average sale price of the shares sold ranging from $7.54 to $7.545 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| November 27, 2018 Filed Nov 28, 2018 21:03 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | Exercise / conversionCommon Stock | 25,000 | $2.90 | $72,500.00 |
DisclosureSEC source: 0001209191-18-060103 · doc4.xml · nonDerivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 20:08 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 87,500 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001209191-18-020144 · doc4.xml · derivative · entry 2 ORDONEZ KATHY · CIK 0001222643 · Director · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 87,500 shares Expires 2028-03-15 F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 20:08 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 43,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-020144 · doc4.xml · nonDerivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,750 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 15 of each of 2019, 2020, 2021, and 2022, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| November 15, 2017 Filed Nov 15, 2017 21:21 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 375,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-17-060879 · doc4.xml · derivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,000 Underlying: Common Stock · 375,000 shares Expires 2027-11-15 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a four year period. Read SEC document |
| May 24, 2017 Filed May 25, 2017 20:13 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $3.81 | $0.00 |
DisclosureSEC source: 0001209191-17-035326 · doc4.xml · derivative · entry 1 ORDONEZ KATHY · CIK 0001222643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-05-24 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.